Abstract:Nonsmall cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide. Herein, we develop a polypeptide-based block ionomer complex formed by anionic methoxy poly(ethylene glycol)-b-poly(L-glutamic acid) (mPEG-b-PLG) and cationic anticancer drug doxorubicin hydrochloride (DOX·HCl) for NSCLC treatment. This complex spontaneously self-assembled into spherical nanoparticles (NPs) in aqueous solutions via electrostatic interaction and hydrophobic stack, with a high loading efficiency (almost 100%) and negative surface charge. DOX·HCl release from the drug-loaded micellar nanoparticles (mPEG-b-PLG-DOX·HCl) was slow at physiological pH, but obviously increased at the acidic pH mimicking the endosomal/lysosomal environment. In vitro cytotoxicity and hemolysis assays demonstrated that the block copolypeptide was cytocompatible and hemocompatible, and the presence of copolypeptide carrier could reduce the hemolysis ratio of DOX·HCl significantly. Cellular uptake and cytotoxicity studies suggested that mPEG-b-PLG-DOX·HCl was taken up by A549 cells via endocytosis, with a slightly slower cellular internalization and lower cytotoxicity compared with free DOX·HCl. The pharmacokinetics study in rats showed that DOX·HCl-loaded micellar NPs significantly prolonged the blood circulation time. Moreover, mPEG-b-PLG-DOX·HCl exhibited enhanced therapeutic efficacy, increased apoptosis in tumor tissues, and reduced systemic toxicity in nude mice bearing A549 lung cancer xenograft compared with free DOX·HCl, which were further confirmed by histological and immunohistochemical analyses. The results demonstrated that mPEG-b-PLG was a promising vector to deliver DOX·HCl into tumors and achieve improved pharmacokinetics, biodistribution and efficacy of DOX·HCl with reduced toxicity. These features strongly supported the interest of developing mPEG-b-PLG-DOX·HCl as a valid therapeutic modality in the therapy of human NSCLC and other solid tumors.

l-Cystine-Crosslinked Polypeptide Nanogel as a Reduction-Responsive Excipient for Prostate Cancer Chemotherapy

Polypeptide Nanogels with Different Functional Cores Promote Chemotherapy of Lung Carcinoma

Mucoadhesive Cationic Polypeptide Nanogel with Enhanced Penetration for Efficient Intravesical Chemotherapy of Bladder Cancer

Reduction-Responsive Chemo-Capsule-Based Prodrug Nanogel for Synergistic Treatment of Tumor Chemotherapy

Nanoscaled Poly(l-Glutamic Acid)/doxorubicin-Amphiphile Complex As Ph-Responsive Drug Delivery System for Effective Treatment of Nonsmall Cell Lung Cancer.

Biocompatible reduction-responsive polypeptide micelles as nanocarriers for enhanced chemotherapy efficacy in vitro

Preparation and evaluation of highly biocompatible nanogels with pH-sensitive charge-convertible capability based on doxorubicin prodrug.

Hydrophilicity/Hydrophobicity Reversable and Redox-Sensitive Nanogels for Anticancer Drug Delivery.

A redox stimuli-responsive superparamagnetic nanogel with chemically anchored DOX for enhanced anticancer efficacy and low systemic adverse effects

Smart Ph/redox Dual-Responsive Nanogels for On-Demand Intracellular Anticancer Drug Release

Enhanced Endocytosis of Acid-Sensitive Doxorubicin Derivatives with Intelligent Nanogel for Improved Security and Efficacy

Therapeutic Polymeric Nanomedicine: GSH-responsive Release Promotes Drug Release for Cancer Synergistic Chemotherapy.

Ph and Reduction Dual-Responsive Nanogel Cross-Linked by Quaternization Reaction for Enhanced Cellular Internalization and Intracellular Drug Delivery

Intelligent nanogels with self-adaptive responsiveness for improved tumor drug delivery and augmented chemotherapy

Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for "on-demand" drug delivery.

Smart chitosan nanogel for targeted doxorubicin delivery, ensuring precise release, and minimizing side effects in Ehrlich ascites carcinoma-bearing mice

X-ray-responsive Polypeptide Nanogel for Concurrent Chemoradiotherapy.

Doxorubicin-loaded polypeptide nanorods based on electrostatic interactions for cancer therapy.

Co-delivery of Paclitaxel and Doxorubicin Using Polypeptide-Engineered Nanogels for Combination Therapy of Tumor

Cancer cell membrane-coated nanogels as a redox/pH dual-responsive drug carrier for tumor-targeted therapy.

Thermo/redox/pH-triple Sensitive Poly(n-Isopropylacrylamide-co-acrylic Acid) Nanogels for Anticancer Drug Delivery.